MicroRNA-145 regulates the proliferation of the human gastric cancer cells by targeting tuftelin 1 (TUFT1)

被引:2
作者
Meng, Pei [1 ]
Xia, Ronglong [1 ]
Shao, Zhihong [1 ]
机构
[1] Wusong Cent Hosp, Dept Gen Surg, Shanghai 200940, Peoples R China
关键词
gastric cancer; micro-RNA; miR-145; apoptosis; tuftelin; 1; flow cytometry; HEPATOCELLULAR-CARCINOMA; INVASION; GROWTH; MIGRATION; PROMOTES;
D O I
10.18388/abp.2020_5798
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNA-145 (miR-145) has been shown to regulate the development of different human cancer. How-ever, the role of miR-145 via modulation of tuftelin 1 (TUFT1) expression has not been studied in gastric can-cer. TUFT1The results showed that gastric cancer tissues and cell lines exhibit significant (P<0.05) downregula-tion of miR-145. Overexpression of miR-145 significantly (P<0.05) inhibited the viability and colony formation of the MGC-803 gastric cancer cells. Annexin V/PI stain-ing revealed that miR-145 exerts its tumor-suppressive effects via induction of apoptosis. The apoptotic cell percentage increased from 5.75% in negative control to 22.95% in miR-145 overexpressing MG-803 cells. This was also accompanied by upregulation of Bax and downregulation of Bcl-2 expression. TargetScan analy-sis and the dual luciferase assay revealed TUFT1 as the functional target of miR-145. The expression of TUFT1 was significantly (P<0.05) upregulated in gastric cancer tissues and cell lines. However, overexpression of miR-145 causes inhibition of the TUFT1 expression. Silenc-ing of TUFT1 mimicked the tumor-suppressive effects of miR-145. However, tuftelin 1 overexpression attenuated the tumor-suppressive effect of miR-145 in MGC-803 gastric cancer cells. Taken together, the results of the present study indicate that miR-145 targets TUFT1 at translational level to exert its tumor suppressive effects in gastric cancer.
引用
收藏
页码:357 / 362
页数:6
相关论文
共 29 条
[1]   Diffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity [J].
Ansari, Shamshul ;
Gantuya, Boldbaatar ;
Vo Phuoc Tuan ;
Yamaoka, Yoshio .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (08)
[2]  
Arun Kanagaraj, 2018, Oncotarget, V9, P18386, DOI 10.18632/oncotarget.24841
[3]   Targeting apoptosis in cancer therapy [J].
Carneiro, Benedito A. ;
El-Deiry, Wafik S. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (07) :395-417
[4]   Functional role of miR-27b in the development of gastric cancer [J].
Chen, Xiaojie ;
Cui, Yejia ;
Xie, Xuhong ;
Xing, Yanfen ;
Yuan, Zhaohu ;
Wei, Yaming .
MOLECULAR MEDICINE REPORTS, 2018, 17 (04) :5081-5087
[5]   MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1 [J].
Feng, Y. ;
Zhu, J. ;
Ou, C. ;
Deng, Z. ;
Chen, M. ;
Huang, W. ;
Li, L. .
BRITISH JOURNAL OF CANCER, 2014, 110 (09) :2300-2309
[6]   Downregulation of MiR-1297 predicts poor prognosis and enhances gastric cancer cell growth by targeting CREB1 [J].
Gao, Wencang ;
Cao, Ying ;
Guo, Piaoting ;
Bao, Xiaoyan ;
Zhu, Hongye ;
Zheng, Jian ;
Yao, Cheng ;
Chen, Dong ;
Yu, Shenquan ;
Chen, Binhai ;
Zhou, Shaoling ;
Pang, Dexiang ;
Chen, Weijian .
BIOMEDICINE & PHARMACOTHERAPY, 2018, 105 :413-419
[7]   Multiple-to-Multiple Relationships between MicroRNAs and Target Genes in Gastric Cancer [J].
Hashimoto, Yutaka ;
Akiyama, Yoshimitsu ;
Yuasa, Yasuhito .
PLOS ONE, 2013, 8 (05)
[8]   MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer [J].
Hu, Mingli ;
Zhu, Shixuan ;
Xiong, Shengwei ;
Xue, Xingxing ;
Zhou, Xiaodong .
ONCOLOGY REPORTS, 2019, 41 (03) :1439-1454
[9]   MicroRNAs serve as a bridge between oxidative stress and gastric cancer (Review) [J].
Huang, Tianhe ;
Wang-Johanning, Feng ;
Zhou, Fuling ;
Kallon, Herbert ;
Wei, Yongchang .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (05) :1791-1800
[10]   RETRACTED: miR-200a-3p plays tumor suppressor roles in gastric cancer cells by targeting KLF12 (Retracted Article) [J].
Jia, Changhe ;
Zhang, Yanrui ;
Xie, Yi ;
Ren, Ying ;
Zhang, Haihui ;
Zhou, Yinglei ;
Gao, Ning ;
Ding, Songze ;
Han, Shuangyin .
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) :3697-3703